Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119005247> ?p ?o ?g. }
- W2119005247 endingPage "26" @default.
- W2119005247 startingPage "316" @default.
- W2119005247 abstract "Hematopoietic malignancies have been shown to depend on cytokine growth factor autocrine/paracrine loops for growth and differentiation. This results in the constitutive activation of cytokine-mediated transcription factors like signal transducer and activators of transcription (STAT) 3 in non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM). Recent evidence demonstrates that cytokines also contribute to a drug-resistant phenotype in many tumor cell types. We hypothesized that inhibitors of the STAT3 pathway would sensitize drug-resistant and endogenous cytokine-dependent NHL and MM tumor cells to the cytotoxic effects of chemotherapeutic drugs. We examined an AIDS-related NHL cell line, 2F7, known to be dependent on interleukin (IL)-10 for survival and an MM cell line, U266, known to be dependent on IL-6 for survival. IL-10 and IL-6 signal the cells through the activation of Janus kinase (JAK)1 and JAK2, respectively. Thus, we investigated the effect of two chemical STAT3 pathway inhibitors, namely, piceatannol (JAK1/STAT3 inhibitor) and tyrphostin AG490 (JAK2/STAT3 inhibitor), on the tumor cells for sensitization to therapeutic drugs. We demonstrate by phosphoprotein immunoblotting analysis and electrophoretic mobility shift analysis that piceatannol and AG490 inhibit the constitutive activity of STAT3 in 2F7 and U266, respectively. Furthermore, piceatannol and AG490 sensitize 2F7 and U266 cells, respectively, to apoptosis by a range of therapeutic drugs including cisplatin, fludarabine, Adriamycin, and vinblastine. The specificity of the inhibitors was corroborated in experiments showing that piceatannol had no effect on U266 and, likewise, AG490 has no effect on 2F7. The sensitization observed by these inhibitors correlated with the inhibition of Bcl-2 expression in 2F7 and Bcl-xL expression in U266. Altogether, these results demonstrate that STAT3 pathway inhibitors are a novel class of chemotherapeutic sensitizing agents capable of reversing the drug-resistant phenotype of cytokine-dependent tumor cells." @default.
- W2119005247 created "2016-06-24" @default.
- W2119005247 creator A5055490703 @default.
- W2119005247 creator A5060085360 @default.
- W2119005247 date "2003-01-01" @default.
- W2119005247 modified "2023-09-23" @default.
- W2119005247 title "Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis." @default.
- W2119005247 cites W1499527462 @default.
- W2119005247 cites W1513880000 @default.
- W2119005247 cites W1550156431 @default.
- W2119005247 cites W1558123369 @default.
- W2119005247 cites W159302622 @default.
- W2119005247 cites W1652716702 @default.
- W2119005247 cites W168754456 @default.
- W2119005247 cites W171552586 @default.
- W2119005247 cites W1841012357 @default.
- W2119005247 cites W1913007537 @default.
- W2119005247 cites W1917630072 @default.
- W2119005247 cites W1969484474 @default.
- W2119005247 cites W1971175458 @default.
- W2119005247 cites W1973596639 @default.
- W2119005247 cites W1979129905 @default.
- W2119005247 cites W1979347549 @default.
- W2119005247 cites W1982421421 @default.
- W2119005247 cites W1982864677 @default.
- W2119005247 cites W1991498850 @default.
- W2119005247 cites W1995997868 @default.
- W2119005247 cites W2003525895 @default.
- W2119005247 cites W2004329597 @default.
- W2119005247 cites W2006379003 @default.
- W2119005247 cites W2012558233 @default.
- W2119005247 cites W2016420942 @default.
- W2119005247 cites W2022215206 @default.
- W2119005247 cites W2024282024 @default.
- W2119005247 cites W2030519257 @default.
- W2119005247 cites W2033336766 @default.
- W2119005247 cites W2034286443 @default.
- W2119005247 cites W2037746465 @default.
- W2119005247 cites W2039975110 @default.
- W2119005247 cites W2041204531 @default.
- W2119005247 cites W2049548558 @default.
- W2119005247 cites W2049819186 @default.
- W2119005247 cites W2056404523 @default.
- W2119005247 cites W2056708769 @default.
- W2119005247 cites W2062932184 @default.
- W2119005247 cites W2067894718 @default.
- W2119005247 cites W2069035291 @default.
- W2119005247 cites W2075262248 @default.
- W2119005247 cites W2089601189 @default.
- W2119005247 cites W2094797375 @default.
- W2119005247 cites W2099494462 @default.
- W2119005247 cites W2100148089 @default.
- W2119005247 cites W2101617873 @default.
- W2119005247 cites W2103031848 @default.
- W2119005247 cites W2107631090 @default.
- W2119005247 cites W2111034338 @default.
- W2119005247 cites W2112212243 @default.
- W2119005247 cites W2115744231 @default.
- W2119005247 cites W2116401711 @default.
- W2119005247 cites W2118310862 @default.
- W2119005247 cites W2122048408 @default.
- W2119005247 cites W2123852291 @default.
- W2119005247 cites W2127048642 @default.
- W2119005247 cites W2128240839 @default.
- W2119005247 cites W2134241373 @default.
- W2119005247 cites W2134582745 @default.
- W2119005247 cites W2135055828 @default.
- W2119005247 cites W2141210982 @default.
- W2119005247 cites W2143811153 @default.
- W2119005247 cites W2150446355 @default.
- W2119005247 cites W2150857908 @default.
- W2119005247 cites W2152210401 @default.
- W2119005247 cites W2258341156 @default.
- W2119005247 cites W2312555199 @default.
- W2119005247 cites W2318698183 @default.
- W2119005247 cites W2322090980 @default.
- W2119005247 cites W2330829715 @default.
- W2119005247 cites W2415581815 @default.
- W2119005247 cites W29766578 @default.
- W2119005247 cites W3140329099 @default.
- W2119005247 cites W42013536 @default.
- W2119005247 cites W2608773137 @default.
- W2119005247 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12538484" @default.
- W2119005247 hasPublicationYear "2003" @default.
- W2119005247 type Work @default.
- W2119005247 sameAs 2119005247 @default.
- W2119005247 citedByCount "76" @default.
- W2119005247 countsByYear W21190052472012 @default.
- W2119005247 countsByYear W21190052472013 @default.
- W2119005247 countsByYear W21190052472014 @default.
- W2119005247 countsByYear W21190052472015 @default.
- W2119005247 countsByYear W21190052472016 @default.
- W2119005247 countsByYear W21190052472017 @default.
- W2119005247 countsByYear W21190052472018 @default.
- W2119005247 countsByYear W21190052472019 @default.
- W2119005247 countsByYear W21190052472020 @default.
- W2119005247 countsByYear W21190052472021 @default.
- W2119005247 countsByYear W21190052472022 @default.